110 related articles for article (PubMed ID: 17216848)
1. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. New formulation of nelfinavir on the way.
TreatmentUpdate; 2003; 15(3):6. PubMed ID: 17216848
[No Abstract] [Full Text] [Related]
2. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Does Roche's nelfinavir cause less diarrhea?
TreatmentUpdate; 2003; 15(3):7. PubMed ID: 17216849
[No Abstract] [Full Text] [Related]
3. FDA approves new versions of two HIV/AIDS drugs.
HIV Clin; 2000; 12(2):11. PubMed ID: 11810829
[No Abstract] [Full Text] [Related]
4. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
5. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
6. FDA notifications. Alternative dosing regimen for atazanavir is approved.
AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
[No Abstract] [Full Text] [Related]
7. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
8. Agenerase approved by FDA.
Gaylord G
Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
[No Abstract] [Full Text] [Related]
9. Nelfinavir (Viracept).
Baker R; Bowers M
BETA; 1997 Mar; ():5. PubMed ID: 11364528
[TBL] [Abstract][Full Text] [Related]
10. Salvage with Nelfinavir doesn't always work.
TreatmentUpdate; 1998 Aug; 10(6):2-3. PubMed ID: 11365702
[TBL] [Abstract][Full Text] [Related]
11. FDA approval: darunavir.
Sax PE
AIDS Clin Care; 2006 Aug; 18(8):71. PubMed ID: 16906668
[No Abstract] [Full Text] [Related]
12. FDA notifications. Accelerated approval of tipranavir.
AIDS Alert; 2005 Nov; 20(11):131. PubMed ID: 16363051
[No Abstract] [Full Text] [Related]
13. FDA approves Aptivus (tipranavir).
Pham PA
Hopkins HIV Rep; 2005 Jul; 17(4):6-7. PubMed ID: 16419308
[No Abstract] [Full Text] [Related]
14. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
15. FDA rapidly approves HIV protease inhibitors for children.
Fox JL
Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
[No Abstract] [Full Text] [Related]
16. Pediatric treatments.
AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
[TBL] [Abstract][Full Text] [Related]
17. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
Huff B
GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
[No Abstract] [Full Text] [Related]
18. TMC114 approved for resistant patients.
AIDS Patient Care STDS; 2006 Oct; 20(10):731. PubMed ID: 17052143
[No Abstract] [Full Text] [Related]
19. New Norvir soft-gel capsule formulation approved by FDA.
Gaylord G
Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
[No Abstract] [Full Text] [Related]
20. FDA notifications. New 600 mg tablet strength for darunavir is approved by FDA.
AIDS Alert; 2008 Apr; 23(4):47. PubMed ID: 19253456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
